60
47
Growth Score
-5 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
288636
Nyrada is a preclinical stage, drug development company.
John Moore: Non-Executive ChairmanPast Role: Acorn Energy, Director and CEO- Ian Dixon: Founder & DirectorPast Role: Noxopharm, Non Executive Director
About the Company
Nyrada is a preclinical stage, drug discovery and development company, specialising in novel small molecule drugs to treat cardiovascular, neurological and chronic inflammatory diseases. The Company has four active programs all targeting market sectors of significant size and considerable unmet need. The two lead programs are a cholesterol lowering
drug and a drug to treat brain injury, specifically stroke andtraumatic brain injury.
